ONTO: HBM Demand And Rigaku Partnership Will Shape Future Upside Potential

Onto Innovation's updated analyst fair value estimate has shifted from about $281 to roughly $352, with analysts citing higher modeled revenue growth, stronger profit margins, and slight adjustments to the discount rate and future P/E assumptions as the reasons for the change.

Analyst Commentary

Recent Street research on Onto Innovation has been active, with several firms adjusting ratings and price targets in both directions. The mix of upgrades, higher targets, and a few target cuts gives you a range of views on how the stock’s valuation lines up with execution and growth expectations.

Bullish Takeaways

Bullish analysts have raised price targets multiple times across recent reports, indicating that their modeled fair values sit above prior levels and that they see room for the stock to track closer to those targets over time.
Several bullish reports reference company commentary on Q1 and the first half of 2026 revenue guidance, which they view as supportive of growth expectations embedded in their forecasts.
One research note highlights a US$240m HBM volume purchase agreement and describes underlying momentum as having improved, which they factor into higher target prices and more constructive growth assumptions.
Upgrades from Neutral to more positive ratings, alongside higher price targets such as US$275, indicate that some analysts now see the risk reward as more favorable than before, given their views on execution and margin outlook.

Bearish Takeaways

Bearish analysts have trimmed price targets on related coverage, which indicates caution around how much upside they are willing to assign based on their current forecasts and valuation frameworks.
Some reports keep ratings at Hold even while nudging targets higher, suggesting that a portion of the Street views the stock as closer to fair value relative to their assumptions for growth and profitability.
Comments around Q4 results being slightly below expectations and the reliance on future guidance to support higher estimates show that not all analysts are fully aligned on the near term execution picture.
The split between more aggressive target hikes and more conservative or reduced targets points to ongoing debate about how sustainable current growth assumptions and margin expectations are within analyst models.

What's in the News

Issued earnings guidance for the second quarter ending June 30, 2026, with expected revenue of US$320 million to US$330 million, GAAP operating margin of 17.8% to 18.7%, GAAP diluted EPS of US$1.09 to US$1.18, and GAAP operating income of US$56.9 million to US$61.7 million (company guidance).
Updated earnings guidance for the first and second quarters of 2026, with first quarter revenue now expected at US$292 million, compared with a prior outlook of US$275 million to US$285 million. Second quarter revenue guidance is set at US$320 million to US$330 million and is described as an 8% increase over the previously shared outlook (company guidance).
Announced a collaboration with Rigaku Holdings Corporation to combine Onto Innovation’s Ai Diffract analysis software with Rigaku’s CD-SAXS platforms for semiconductor process control, along with an agreement to acquire 27% of Rigaku for about US$710 million. Closing is targeted for the second half of 2026, subject to regulatory and other customary approvals (company announcement).
Launched the Dragonfly G5 inspection and metrology system, including orders in the double digits from a high bandwidth memory manufacturer for HBM4 ramp, and plans to begin shipments of Dragonfly G5 and 3Di technology in the second quarter of 2026 (product announcement).
Reported successful qualification of the Dragonfly G5 platform for 2.5D advanced packaging applications, with initial shipments expected in June. The company commented that demand for Dragonfly platforms is expected to grow more than 50% in 2026 compared with 2025 (product announcement).

Valuation Changes

Fair Value: The updated analyst fair value estimate has moved from about $281 to roughly $352, indicating a higher modeled valuation level.
Discount Rate: The discount rate has risen slightly from about 10.49% to about 10.92%, reflecting a modest change in the risk or return hurdle used in the models.
Revenue Growth: The revenue growth assumption has increased from about 18.19% to about 22.91%, pointing to a higher growth rate embedded in forecasts.
Net Profit Margin: The net profit margin assumption has risen from about 25.84% to about 30.86%, indicating a higher expected level of profitability in the updated model.
Future P/E: The future P/E multiple has been reduced from about 45.90x to about 42.31x, signaling a slightly more conservative valuation multiple applied to projected earnings.

6 views

Key Takeaways

Surging demand for advanced chip packaging and new architectures is driving strong growth, higher margins, and increased market share for Onto Innovation.
Strategic acquisitions and regional manufacturing initiatives are expanding capabilities, reducing risk, and boosting earnings, while robust end-market trends support long-term revenue acceleration.
Heavy dependence on customer demand rebound, exposure to geopolitical risks, revenue concentration, high R&D costs, and acquisition integration challenges threaten long-term revenue and margin stability.

Catalysts

About Onto Innovation

Engages in the design, development, manufacture, and support of process control tools that performs optical metrology and inspection worldwide.What are the underlying business or industry changes driving this perspective?

The accelerating adoption of AI packaging and advanced 2.5D/3D logic architectures is driving a major step up in demand for Onto Innovation's next-generation Dragonfly systems, with strong customer pull and new applications expanding both revenue and potential gross margin through higher ASPs and increased market share within leading-edge chip production.
The pending Semilab acquisition will immediately expand Onto's product portfolio into electrical surface metrology and materials analysis-capabilities specifically in demand as industry transitions to exotic materials and heterogeneous integration-enabling both direct revenue accretion (~$130M annualized) and gross/operating margin uplift, further increasing earnings per share by 10%+ in the first year post-deal.
Regional manufacturing initiatives ("region-for-region" strategy) are supporting operational resilience and mitigating future tariff exposure, ensuring more reliable global delivery while lowering cost of goods and preserving gross margin, with the impact expected to show up in improved net margins in 2026.
Market commentary indicates a sharp Q4 rebound in both AI packaging and advanced node spending, with specialty device and advanced packaging revenue expected to approach previous peak levels and advanced node revenue anticipated to almost double in 2025 vs. 2024-suggesting the near-term revenue dip is temporary and masking underlying demand strength, with a setup for outsized top-line growth.
Onto's ongoing penetration into new applications (e.g., co-packaged optics, die stacking, wafer bonding) and increasing wallet share at key customers reflect the company's ability to capitalize on the proliferation of connected devices and electrification trends, enhancing revenue diversification and resilience while supporting both revenue stability and margin expansion.

Onto Innovation Earnings and Revenue Growth

Onto Innovation Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Onto Innovation's revenue will grow by 22.9% annually over the next 3 years.
Analysts assume that profit margins will increase from 10.3% today to 30.9% in 3 years time.
Analysts expect earnings to reach $590.6 million (and earnings per share of $9.95) by about May 2029, up from $106.4 million today.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 42.3x on those 2029 earnings, down from 127.0x today. This future PE is lower than the current PE for the US Semiconductor industry at 61.7x.
Analysts expect the number of shares outstanding to grow by 1.51% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 10.92%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

The significant reliance on a rebound in customer demand, especially in AI packaging and advanced nodes for the fourth quarter and 2026, exposes Onto Innovation to the risk of a cyclical downturn or delays in customer spending, which could negatively impact revenue and earnings if the anticipated rebound fails to materialize as strongly or as quickly as forecasted.
The company faces persistent geopolitical risks and tariff exposure, with ongoing uncertainties surrounding global trade regulations and tariffs-particularly after mentioning recent 100% tariffs announcements-which could disrupt supply chains or increase costs, thereby pressuring gross margins and net earnings, especially if mitigation strategies do not fully succeed.
Onto's business performance remains closely tied to a small number of major customers in high-growth segments (like AI logic packaging and HBM), and a failure to diversify more broadly may lead to revenue concentration risks; any shift of customer preference toward alternative vendors or in-house solutions could reduce long-term revenue stability.
The need to maintain high R&D investment to keep pace with rapid advances in semiconductor technology and customer requirements (e.g., new architectures, advanced packaging, evolving materials) could exert ongoing pressure on net margins if revenue growth slows or if new products (like the next-gen Dragonfly) do not achieve expected market adoption.
Integration risks associated with the Semilab acquisition, including realizing anticipated synergies and new product expansion into advanced nodes and packaging, may not materialize as projected; should integration falter or cross-selling opportunities disappoint, the anticipated accretive impact on both revenue and EPS could be mitigated, affecting long-term earnings growth.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $352.14 for Onto Innovation based on their expectations of its future earnings growth, profit margins and other risk factors.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $1.9 billion, earnings will come to $590.6 million, and it would be trading on a PE ratio of 42.3x, assuming you use a discount rate of 10.9%.
Given the current share price of $271.77, the analyst price target of $352.14 is 22.8% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Onto Innovation?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Analysts Raise Onto Innovation Price Target Amid Growth Momentum and Market Share Recovery Efforts